About
Enzyme Treatment
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
4
As Collaborator
6
Total Enrollment
61,988
By Phase
PHASE3: 4NA: 3
By Status
ACTIVE_NOT_RECRUITING: 4COMPLETED: 4TERMINATED: 2
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06703190Collaborator
Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine
N/AActive, not recruiting
1 participants
Started: Nov 25, 2024 · Completed: Dec 31, 2025
NCT05357404Collaborator
Age and Sex-Specific PREValence of AcqUirEd VALVular Heart DiseasE
N/AActive, not recruiting
2,870 participants
Started: Apr 21, 2022 · Completed: Apr 30, 2025
NCT05160636Collaborator
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza
N/AActive, not recruiting
999 participants
Started: Jan 31, 2022 · Completed: Feb 28, 2026
NCT02649959Lead Sponsor
An Open Label Study of CM-AT for the Treatment of Children With Autism
PHASE3Active, not recruiting
405 participants
Started: Oct 31, 2015 · Completed: Jan 31, 2028
NCT02410902Lead Sponsor
A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study)
PHASE3Completed
190 participants
Started: May 13, 2015 · Completed: Dec 22, 2017
Locations (1)
Headquarters
Rye Brook, NY, United States
Map
Loading map...